- Home
- ANNX vs GCBC Comparison
ANNX vs GCBC Comparison
Compare ANNX & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- GCBC
- Stock Information
- Founded
- ANNX 2011
- GCBC 1889
- Country
- ANNX United States
- GCBC United States
- Employees
- ANNX N/A
- GCBC N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- GCBC Banks
- Sector
- ANNX Health Care
- GCBC Finance
- Exchange
- ANNX Nasdaq
- GCBC Nasdaq
- Market Cap
- ANNX 362.4M
- GCBC 364.4M
- IPO Year
- ANNX 2020
- GCBC 1998
- Fundamental
- Price
- ANNX $1.46
- GCBC $21.41
- Analyst Decision
- ANNX Strong Buy
- GCBC
- Analyst Count
- ANNX 5
- GCBC 0
- Target Price
- ANNX $18.67
- GCBC N/A
- AVG Volume (30 Days)
- ANNX 2.2M
- GCBC 79.4K
- Earning Date
- ANNX 05-12-2025
- GCBC 04-29-2025
- Dividend Yield
- ANNX N/A
- GCBC 1.69%
- EPS Growth
- ANNX N/A
- GCBC N/A
- EPS
- ANNX N/A
- GCBC 1.54
- Revenue
- ANNX N/A
- GCBC $65,848,000.00
- Revenue This Year
- ANNX N/A
- GCBC N/A
- Revenue Next Year
- ANNX N/A
- GCBC N/A
- P/E Ratio
- ANNX N/A
- GCBC $13.90
- Revenue Growth
- ANNX N/A
- GCBC N/A
- 52 Week Low
- ANNX $1.29
- GCBC $20.00
- 52 Week High
- ANNX $7.85
- GCBC $37.25
- Technical
- Relative Strength Index (RSI)
- ANNX 30.77
- GCBC 34.56
- Support Level
- ANNX $1.40
- GCBC $21.12
- Resistance Level
- ANNX $1.68
- GCBC $23.13
- Average True Range (ATR)
- ANNX 0.18
- GCBC 1.20
- MACD
- ANNX 0.00
- GCBC 0.02
- Stochastic Oscillator
- ANNX 19.13
- GCBC 33.25
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About GCBC Greene County Bancorp Inc.
Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.